Properties
Description
BMS-688521 is an effective cytoskeleton inhibitor, that has the ability to prevent the pathway of cytoskeletal signaling by inhibiting integrin.
Molecular Formula
C26H19Cl2N5O4
Titer
Free from inappropriate visible particulates, foreign matter, discoloration, or other defects
Stability
In its lyophilized form, the chemical remains stable for 36 months.
Quality Level
Research grade
Applications
BMS-688521 is a cytoskeletal signaling inhibitor that can be studied extensively for its potential therapeutic applications in the treatment of inflammatory bowel diseases (IBD) such as Crohn’s disease and ulcerative colitis by blocking the interaction of integrin α4β7 with its ligands in the gut.
Storage
Store at -20ºC, and keep desiccated.
